| EpigenTek Launches Complete ISAC™ Platform — Rapid, Precise Chromatin Accessibility Profiling Published 02/07/2025 |
|||
FARMINGDALE, NY – February 2025 – EpigenTek continues to revolutionize epigenetics research with tools that combine speed, precision, and ease-of-use, helping scientists move from samples to insights faster than ever. We are thrilled to introduce our ISAC (In Situ Accessible Chromatin) platform, delivering a streamlined and unbiased solution for chromatin accessibility analysis. The platform includes three complementary kits that preserve chromatin integrity, minimize bias, and accelerate workflows. EpiNext™ In Situ Accessible Chromatin (ISAC) Preparation Kit (P-1072)
![]() qPCR data of DNA purified from in situ accessible chromatin prepared with the EpiNext™ ISAC Preparation Kit, using 30,000 MCF-7 cells as input. Pink (HBB) and green (GAPDH) lines: Enzyme-treated; Blue (HBB) and Brown (GAPDH) lines: Untreated. EpiNext™ ISAC Library Preparation Kit (P-1057)
EpiNext™ In Situ Accessible Chromatin Sequencing (ISAC-seq) Kit (P-1073)
![]() Representative fragment size data of DNA library prepared with the EpiNext™ ISAC seq Kit, using 30,000 MCF-7 cells as input.
EpigenTek’s ISAC workflow provides researchers with:
EpigenTek is a New York-based biotechnology company that focuses on developing and providing innovative technologies, services, and products as a complete and systematic solution for epigenetics-related research and drug discovery. For more information, technical resources, or to request a quote, please visit www.epigentek.com. |
|||
| Terms & Conditions | Privacy Policy | Site Map |
| Copyright © EpigenTek Group Inc. All rights reserved. |